Reports
Reports
Sale
The China hemodialysis and peritoneal dialysis market size was valued at USD 9.95 billion in 2023, driven by the rising incidence of renal failures across the region. The market is expected to grow at a CAGR of 8.2% during the forecast period of 2024-2032, with the values likely to rise from USD 10.77 billion in 2024 to USD 20.23 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Peritoneal dialysis and hemodialysis are alternatives for dialysis for patients with end-stage renal disease in whom preventive kidney transplantation is not possible. Hemodialysis is performed through a machine that filters the body’s blood and toxins through a dialyzer (also known as an artificial kidney). In peritoneal dialysis, the tiny blood vessels inside the abdominal lining filter blood with the help of a dialysis solution.
The China hemodialysis and peritoneal dialysis market value is being driven by factors like growing ESRD patients, increasing prevalence of diabetes and high blood pressure, and the growing number of dialysis facilities across the country. The growing preference for dialysis treatments among consumers owing to the risk associated with kidney transplants is expected to aid the industry growth over the forecast period.
With the help of increasing mergers and partnerships between native and international companies, the region is witnessing a notable emphasis on integrating new solutions to offer better patient alternatives. Japan based Terumo Corporation and WEGO Terumo (Weihai) Medical Products CO., Ltd., received the National Medical Products Administration (NMPA) approval to market and manufacture the first neutralized peritoneal dialysis solution in the country. Such partnerships play a critical role in fueling the hemodialysis and peritoneal dialysis market growth.
The growing convergence of digital and artificial intelligence enabled devices is also expected to boost market growth. With government and private initiatives, there is high emphasis on educating the healthcare professionals to properly use modern technology.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type
Market Breakup by Dialysis Site
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The China hemodialysis and peritoneal dialysis market demand is being driven by the rising health concerns among consumers, the growing disposable incomes, and the rapidly emerging economies within the region. With the advent of minimally invasive tools, the patient volume has been relatively higher owing to convenient procedures and faster recovery period.
With a significant rise in healthcare investments, there has been a notable increase in the number of dialysis centers in China. The segment of hemodialysis will hold the largest share in the market, primarily due to greater accessibility of HD centers, an increasing number of public dialysis centers, increased knowledge and understanding of the management of HD, reimbursement coverage, and socio-demographic factors. In addition, the growing focus of key players for expanding their business in the country will boost the hemodialysis and peritoneal dialysis market share globally as well.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Product and Services |
|
Breakup by Dialysis Site |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 China Hemodialysis and Peritoneal Dialysis Market Overview
3.1 China Hemodialysis and Peritoneal Dialysis Market Historical Value (2017-2023)
3.2 China Hemodialysis and Peritoneal Dialysis Market Forecast Value (2024-2032)
4 China Hemodialysis and Peritoneal Dialysis Market Landscape
4.1 China Hemodialysis and Peritoneal Dialysis Developers’ Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 China Hemodialysis and Peritoneal Dialysis Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 China Hemodialysis and Peritoneal Dialysis Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 China Hemodialysis and Peritoneal Dialysis Market Segmentation
6.1 China Hemodialysis and Peritoneal Dialysis Market by Type
6.1.1 Market Overview
6.1.2 Hemodialysis
6.1.2.1 Conventional Hemodialysis
6.1.2.2 Daily Hemodialysis
6.1.2.3 Nocturnal Hemodialysis
6.1.3 Peritoneal Dialysis
6.1.3.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
6.1.3.2 Automated Peritoneal Dialysis (APD)
6.2 China Hemodialysis and Peritoneal Dialysis Market by Product and Services
6.2.1 Market Overview
6.2.2 Equipment
6.2.2.1 Dialysis Machines
6.2.2.2 Dialyzers
6.2.2.3 Bloodline Systems
6.2.2.4 Others
6.2.3 Consumables
6.2.3.1 Catheters
6.2.3.2 Peritoneal Dialysis Solution
6.2.3.3 Bloodline Tubing Sets
6.2.3.4 Others
6.2.4 Drugs
6.2.5 Services
6.3 China Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
6.3.1 Market Overview
6.3.2 In-Center Dialysis
6.3.3 Home Dialysis
6.4 China Hemodialysis and Peritoneal Dialysis Market by Region
6.4.1 Market by Cities
6.4.2 Shanghai
6.4.3 Zhejiang
6.4.4 Guangdong
6.4.5 Jiangsu
6.4.6 Beijing
7 Shanghai Hemodialysis and Peritoneal Dialysis Market
7.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2017-2023)
7.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2024-2032)
7.3 Hemodialysis and Peritoneal Dialysis Market by Type
7.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
8 Zhejiang Hemodialysis and Peritoneal Dialysis Market
8.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2017-2023)
8.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2024-2032)
8.3 Hemodialysis and Peritoneal Dialysis Market by Type
8.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
9 Guangdong Hemodialysis and Peritoneal Dialysis Market
9.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2017-2023)
9.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2024-2032)
9.3 Hemodialysis and Peritoneal Dialysis Market by Type
9.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
10 Jiangsu Hemodialysis and Peritoneal Dialysis Market
10.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2017-2023)
10.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2024-2032)
10.3 Hemodialysis and Peritoneal Dialysis Market by Type
10.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
11 Beijing Hemodialysis and Peritoneal Dialysis Market
11.1 Hemodialysis and Peritoneal Dialysis Market Historical Value (2017-2023)
11.2 Hemodialysis and Peritoneal Dialysis Market Forecast Value (2024-2032)
11.3 Hemodialysis and Peritoneal Dialysis Market by Type
11.4 Hemodialysis and Peritoneal Dialysis Market by Dialysis Site
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Regulatory Framework
15 Supplier Landscape
15.1 Asahi Kasei Medical Co., ltd.
15.1.1 Financial Analysis
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Shandong Weigao Group Medical Polymer Company Limited
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Shenzhen Landwind Industry Co., Ltd.
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Baxter International Inc.
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 B.Braun Melsungen AG
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Davita Healthcare Partners Inc.
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Fresenius Medical Care AG & Co. KGaA
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Nikkiso Co., Ltd.
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Nipro Corporation
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 NxStage Medical, Inc.
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 China Hemodialysis and Peritoneal Dialysis Market - Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 9.95 billion in 2023, driven by the rising prevalence of renal failures across the region.
The market is anticipated to grow at a CAGR of 8.2% during the forecast period of 2024-2032, likely to reach a market value of USD 20.23 billion by 2032.
The current market trend is around rising native and international mergers between companies to bring new and innovative patient solutions. Japan based Terumo Corporation and WEGO Terumo (Weihai) Medical Products CO., Ltd, launched neutral peritoneal dialysis solution gained the regulatory approval from the National Medical Products Administration (NMPA), which entered the Chinese market in the beginning of 2023.
Based on types, the market is divided into hemodialysis and peritoneal dialysis. Hemodialysis is further divided into conventional hemodialysis, daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis, on the other hand, is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD).
It broadly includes equipment, consumables, drugs, and services. Equipment is further segmented into dialysis machines, dialyzers, and bloodline systems, among others. Consumables include catheters, peritoneal dialysis solution, and bloodline tubing sets, among others.
In-center dialysis and home dialysis are common sites for the market.
The major regions of the market include Shanghai, Zhejiang, Guangdong, Jiangsu, and Beijing.
Key players involved in the market are Asahi Kasei Medical Co., ltd., Shandong Weigao Group Medical Polymer Company Limited, Shenzhen Landwind Industry Co., Ltd., Baxter International Inc., B.Braun Melsungen AG, Davita Healthcare Partners Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation and NxStage Medical, Inc.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.